Ainstein Fin-Tech
中Account
Menu
Trader PathProductsResearch Library
Evidence
METHODOLOGYSELECTED WORKTRACK RECORDRESEARCH STANDARD
PricingAccount中Start a conversation

PRODUCTS

Ready to use, with boundaries you can inspect.

Ainstein builds the backtesting and validation framework, then delivers usable TradingView products. Every product publishes its role, limits, version and health status.

Read the Validation Passport first.

Statuses reflect only evidence approved for public release. Private research detail is labelled clearly.

TSLA

TSLA Intraday Flow

Product detail
Timeframe
Standard 1 minute
Session
U.S. RTH
Process role
execute

Airv1.0.0Under Review

Prov2.1.0Under Review

In-sampleComplete
Walk-forward OOSComplete
Monte CarloNot public
Release monitoringComplete

Intended use

Read evolving TSLA intraday research context on the documented chart and session.

Public assumptions

Standard one-minute TSLA candlesticks during the documented regular-hours session.

Monitoring policy

Monthly health review with controlled releases only when evidence passes the release gate.

Claims boundary

Research context only. No broker connection, personalised instruction or performance promise.

Primary limits

  • TSLA only
  • Standard one-minute chart only
  • States are context, not orders
Air

Simplified public protected context

Pro

Expanded lifecycle, alerts and Backtest companion

NQ / MNQ / QQQ

NASDAQ Intraday Flow

Product detail
Timeframe
Standard 1 minute
Session
U.S. RTH
Process role
execute

Airv1.0.0Under Review

Prov2.0.0Under Review

In-sampleComplete
Walk-forward OOSComplete
Monte CarloNot public
Release monitoringComplete

Intended use

Use one documented research interface across the supported NASDAQ charts.

Public assumptions

NQ, MNQ or QQQ on a standard one-minute chart during the documented session.

Monitoring policy

Monthly health review with product-specific data, validation and release gates.

Claims boundary

Product states are informational research context and never execution instructions.

Primary limits

  • NQ, MNQ and QQQ only
  • Read each chart independently
  • Rebuild alerts after material versions
Air

Simplified three-symbol context

Pro

Expanded lifecycle and NQ Backtest companion

NASDAQ-100

Ainstein TECH Momentum 10

Product detail
Timeframe
Monthly
Session
Monthly release
Process role
execute

Prov1.0.0Under Review

In-sampleNot public
Walk-forward OOSNot public
Monte CarloNot public
Release monitoringComplete

Intended use

Review approved monthly targets, changes and cash allocation from an external selection engine.

Public assumptions

Monthly release workflow for the documented NASDAQ-100 universe.

Monitoring policy

Every release is approved before current targets and changes are published.

Claims boundary

A research product, not personalised portfolio advice or a guarantee of relative performance.

Primary limits

  • Monthly, not intraday
  • Up to ten stocks
  • No free Air or trial
Pro

Current approved targets and monthly reminders

Three product families with explicit delivery boundaries.

Each product stays Under Review until its own data, backtest, operational and release gates are approved.

Choose only the product workflow you use.

Each Pro is shown here at USD 30 monthly. The intraday products retain the account-level 7-day trial; TECH Momentum 10 has no free trial.

Compare Pro subscriptions